Literature DB >> 3902506

Structural differences in the cell binding region of human fibronectin molecules isolated from cultured normal and tumor-derived human cells.

L Borsi, G Allemanni, P Castellani, C Rosellini, A Di Vinci, L Zardi.   

Abstract

Fibronectins isolated from human plasma (pFN) and from the conditioned media of normal (N-cFN) and tumor (T-cFN) human cells were compared by cathepsin D digestion followed by immunostaining of released fragments with the monoclonal antibody 3E3, specific for the cell binding site. Two different staining patterns were obtained, one specific for pFN and N-cFN, the second common to fibronectins from the 3 different kinds of tumors studied. This indicates structural differences between N-cFN and T-cFN in the cell binding region of the fibronectin molecule.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3902506     DOI: 10.1016/0014-5793(85)80045-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Immunophenotype of SV40-T gene transfected epithelial cell lines derived from human benign breast tumors.

Authors:  H Raux; P Planchon; F Chraibi-Hajji; V Magnien; V Sallé; D Brouty-Boyé
Journal:  In Vitro Cell Dev Biol       Date:  1992 Jul-Aug

2.  Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon.

Authors:  L Zardi; B Carnemolla; A Siri; T E Petersen; G Paolella; G Sebastio; F E Baralle
Journal:  EMBO J       Date:  1987-08       Impact factor: 11.598

Review 3.  Human fibronectin extra domain B as a biomarker for targeted therapy in cancer.

Authors:  Relinde I Y Lieverse; Damiënne Marcus; Alexander M A van der Wiel; Evert J Van Limbergen; Jan Theys; Ala Yaromina; Philippe Lambin; Ludwig J Dubois
Journal:  Mol Oncol       Date:  2020-06-15       Impact factor: 6.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.